« Return to News | Drug Sponsors

Pfizer puts Sandwich R&D site on market

Tuesday, June 14, 2011 02:28 PM

Pfizer's giant research base at Sandwich, southern England, has been officially put on the market by CB Richard Ellis, according to Reuters. U.S.-based Pfizer in February decided to close the site.

The commercial real estate services firm said it would market the 3 million-square-foot site, where Viagra was invented, under the new name "Discovery Park."

The name reflects the hope that at least some of the buildings at the facility, which employs 2,400 people, will continue to be used for research work.

Sandwich is Pfizer's biggest R&D facility in Europe and the largest R&D site of any foreign-owned drug maker in Britain. It has been a base for medicine discovery for Pfizer since 1954.

Finding new tenants interested in continuing the site's work in pharmaceutical research is unlikely to be easy, given over-capacity in drug R&D worldwide that has led to a number of similar closures by other companies.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.